• Angiotensin III (human, mouse): Molecular Mechanisms and Tra

  2026-05-03

  Explore the molecular mechanisms of Angiotensin III (human, mouse), a critical peptide in RAAS signaling. This article reveals advanced assay insights and translational applications, offering a distinct, in-depth perspective for cardiovascular and antiviral research.

• Morphological Profiling Reveals HSPB7 as a Modifier in Titin

  2026-05-02

  This study introduces CARDIO, a high-content morphological profiling assay that enables systematic analysis of genetic perturbations in human cardiomyocytes. The authors identify HSPB7 as a novel genetic modifier that can rescue contractile dysfunction in titin-deficient models, opening avenues for targeted heart failure research.

• WNT5a/GSK3/β-catenin Axis Controls Adipogenesis in Muscle FA

  2026-05-01

  This study identifies the WNT5a/GSK3/β-catenin pathway as a crucial regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological screening, single-cell analysis, and transcriptomics, the authors demonstrate how modulating this axis can limit fat infiltration and support muscle regeneration, with important implications for myopathy research.

• Eltanexor-Mediated XPO1 Inhibition Suppresses Colorectal Tum

  2026-05-01

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, reduces colorectal cancer tumorigenesis by modulating the Wnt/β-catenin pathway and decreasing COX-2 expression. The findings support XPO1 inhibition as a chemopreventive strategy and highlight Eltanexor’s translational potential in colorectal and other cancer models.

• Sodium Ascorbate: A Mechanistic Gateway for Translational On

  2026-04-30

  This article explores sodium ascorbate’s unique mechanistic role in cancer research, with a focus on glioblastoma multiforme. By synthesizing recent evidence, strategic guidance, and advanced product insights, we provide translational researchers with a roadmap for leveraging sodium ascorbate’s ROS-inducing properties and necrotic tumor cell death pathway. This piece builds on prior technical guides and positions APExBIO’s Sodium Ascorbate as an essential tool for contemporary oncology workflows.

• UBE2F-SAG Neddylation of RHEB Activates mTORC1 in Liver Canc

  2026-04-30

  This study uncovers a novel regulatory mechanism in which the UBE2F-SAG axis mediates neddylation of RHEB, leading to enhanced mTORC1 activity and aggravation of liver tumorigenesis. The findings highlight the central role of RHEB neddylation in hepatocellular carcinoma and suggest new therapeutic targets for metabolic liver disease.

• KR-12–Cu(II) Interactions: Theoretical and Experimental Insi

  2026-04-29

  This study applies advanced computational and experimental methods to elucidate the binding modes of Cu(II) ions with KR-12, a minimal antimicrobial peptide derived from human cathelicidin LL-37. The findings reveal precise peptide fragments involved in metal coordination, informing future design of antimicrobial agents and biomolecular conjugates.

• Mitomycin C: Mechanistic Precision for Translational Oncolog

  2026-04-29

  This thought-leadership article explores how Mitomycin C, an antitumor antibiotic, is uniquely positioned for translational cancer research. Integrating mechanistic insight, protocol optimization, and strategic guidance, the piece offers actionable recommendations for leveraging Mitomycin C in apoptosis signaling and combination therapy—especially in p53-independent models. Drawing on recent evidence and competitive analysis, the article advances the dialogue beyond standard product narratives and provides a roadmap for researchers to maximize experimental reproducibility and translational impact.

• Sulfo-Cy3 NHS Ester: Precision Fluorescent Labeling in Vascu

  2026-04-28

  Explore how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, advances precision protein labeling for vascular biology and stemlike capillary analysis. Discover unique insights integrating mechanistic breakthroughs with practical assay protocol guidance.

• Dorsomorphin (Compound C): Unraveling Metabolic Rewiring in

  2026-04-28

  Explore how Dorsomorphin (Compound C) empowers researchers to dissect AMPK and BMP signaling in bone formation, with a special focus on metabolic rewiring and assay optimization. Gain advanced insights and practical parameters for leveraging this inhibitor in osteogenic and metabolic studies.

• Aggregation Analysis of GnRH Antagonists via NMR and MD Simu

  2026-04-27

  This study systematically evaluated the aggregation behavior of structurally similar therapeutic peptides—including degarelix—using both 1H NMR spectroscopy and all-atom molecular dynamics (AA-MD) simulations. The findings offer molecular-level insights into aggregate formation, reveal differences in counterion incorporation, and suggest robust, non-invasive tools for early-stage peptide drug formulation.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-27

  Wang et al. identify a novel METTL16-SENP3-LTF axis that confers resistance to ferroptosis in hepatocellular carcinoma (HCC), promoting tumorigenesis via modulation of iron metabolism and RNA methylation. Their findings offer mechanistic insight and highlight new targets for sensitizing HCC to ferroptotic cell death.

• GSK2606414: Precision PERK Inhibitor for ER Stress Research

  2026-04-26

  GSK2606414 empowers researchers to dissect ER stress and unfolded protein response pathways with nanomolar precision, facilitating advanced interrogation of inflammation and cell death in disease models. This guide translates the latest mechanistic insights into actionable workflows and troubleshooting strategies, establishing APExBIO’s GSK2606414 as a gold-standard tool for selective PERK inhibition.

• Acetoacetic acid sodium salt: Core Ketone Body for Metabolic

  2026-04-25

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is a benchmark ketone body metabolite crucial for energy metabolism and diabetes research. Its high purity, defined solubility, and validated analytical profile enable reproducible studies in fatty acid catabolism and diabetic ketoacidosis. This dossier presents evidence, protocols, and usage boundaries based on verifiable sources.

• N1-Methylpseudouridine: Reliable mRNA Modification for Viabi

  2026-04-24

  This article explores how N1-Methylpseudouridine (SKU B8340) addresses common challenges in cell viability, proliferation, and cytotoxicity assays. Drawing on published data and validated protocols, we illustrate practical solutions for enhanced mRNA translation, reduced immunogenicity, and experimental reproducibility—highlighting when and why to choose SKU B8340 for robust research outcomes.

15739 records 1/1050 page Next 12345 下5页 Last page